L. J. Montaner

This study shows that Gal-9 treatment during ART increases HIV DNA and RNA in tissues of humanized mice, suggesting it promotes HIV persistence.

This study identifies phenotypic and epigenetic heterogeneity in the HIV-1 infected CD4+ T cell reservoir using single-cell multiomic profiling of ART-treated individuals.

This paper identifies (-)-hopeaphenol and related stilbenoids as potent inhibitors of SARS-CoV-2 entry across multiple variants by blocking spike protein-ACE2 interaction.

This study links phospholipid and lysophospholipid levels to faster HIV rebound after treatment interruption, suggesting their role in viral persistence and inflammation.

This study identifies non-invasive plasma glycomic and metabolic biomarkers that predict viral rebound after HIV treatment interruption with high accuracy.

Anti-α4β7 therapy reduces lymphoid aggregates in the gastrointestinal tract of HIV-1 infected individuals with mild inflammatory bowel disease.